Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Sanara MedTech (SMTI) Invested Capital (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Invested Capital for 15 consecutive years, with $6.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Invested Capital fell 84.41% year-over-year to $6.1 million, compared with a TTM value of $6.1 million through Sep 2025, down 84.41%, and an annual FY2024 reading of $38.9 million, down 28.31% over the prior year.
  • Invested Capital was $6.1 million for Q3 2025 at Sanara MedTech, down from $35.4 million in the prior quarter.
  • Across five years, Invested Capital topped out at $54.3 million in Q4 2023 and bottomed at $6.1 million in Q3 2025.
  • Average Invested Capital over 5 years is $37.9 million, with a median of $39.5 million recorded in 2024.
  • The sharpest move saw Invested Capital skyrocketed 477.03% in 2021, then tumbled 84.41% in 2025.
  • Year by year, Invested Capital stood at $30.2 million in 2021, then soared by 38.37% to $41.7 million in 2022, then surged by 30.11% to $54.3 million in 2023, then decreased by 28.31% to $38.9 million in 2024, then tumbled by 84.2% to $6.1 million in 2025.
  • Business Quant data shows Invested Capital for SMTI at $6.1 million in Q3 2025, $35.4 million in Q2 2025, and $36.7 million in Q1 2025.